192 related articles for article (PubMed ID: 18081229)
1. Two distinct pathways of p16 gene inactivation in gallbladder cancer.
Tadokoro H; Shigihara T; Ikeda T; Takase M; Suyama M
World J Gastroenterol; 2007 Dec; 13(47):6396-403. PubMed ID: 18081229
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung.
Awaya H; Takeshima Y; Amatya VJ; Furonaka O; Tagawa K; Kohno N; Inai K
Pathol Int; 2004 Jul; 54(7):486-9. PubMed ID: 15189501
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype.
Chapman EJ; Harnden P; Chambers P; Johnston C; Knowles MA
Clin Cancer Res; 2005 Aug; 11(16):5740-7. PubMed ID: 16115911
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the p16(ink4a) gene in resected nonsmall cell lung tumors and exfoliated cells within sputum.
Chen JT; Chen YC; Wang YC; Tseng RC; Chen CY; Wang YC
Int J Cancer; 2002 Apr; 98(5):724-31. PubMed ID: 11920642
[TBL] [Abstract][Full Text] [Related]
7. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
[TBL] [Abstract][Full Text] [Related]
8. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
10. p14ARF deletion and methylation in genetic pathways to glioblastomas.
Nakamura M; Watanabe T; Klangby U; Asker C; Wiman K; Yonekawa Y; Kleihues P; Ohgaki H
Brain Pathol; 2001 Apr; 11(2):159-68. PubMed ID: 11303791
[TBL] [Abstract][Full Text] [Related]
11. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma.
Ohta S; Uemura H; Matsui Y; Ishiguro H; Fujinami K; Kondo K; Miyamoto H; Yazawa T; Danenberg K; Danenberg PV; Tohnai I; Kubota Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):81-91. PubMed ID: 19101490
[TBL] [Abstract][Full Text] [Related]
12. [Inactivation of CDKN2A gene (p16) in gallbladder carcinoma].
Roa JC; Vo Q; Araya JC; Villaseca M; Guzmán P; Ibacache GS; de Aretxabala X; Roa I
Rev Med Chil; 2004 Nov; 132(11):1369-76. PubMed ID: 15693199
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
[TBL] [Abstract][Full Text] [Related]
14. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
Merbs SL; Sidransky D
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):779-83. PubMed ID: 10067984
[TBL] [Abstract][Full Text] [Related]
15. Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population.
Tran TN; Liu Y; Takagi M; Yamaguchi A; Fujii H
J Oral Pathol Med; 2005 Mar; 34(3):150-6. PubMed ID: 15689228
[TBL] [Abstract][Full Text] [Related]
16. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of the p16 gene and loss of its protein expression is correlated with tumor progression in extrahepatic bile duct carcinomas.
Hong SM; Choi J; Ryu K; Ro JY; Yu E
Arch Pathol Lab Med; 2006 Jan; 130(1):33-8. PubMed ID: 16390235
[TBL] [Abstract][Full Text] [Related]
18. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer.
Tsutsumi M; Tsai YC; Gonzalgo ML; Nichols PW; Jones PA
Oncogene; 1998 Dec; 17(23):3021-7. PubMed ID: 9881704
[TBL] [Abstract][Full Text] [Related]
19. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA
Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771
[TBL] [Abstract][Full Text] [Related]
20. Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma.
Tanaka R; Wang D; Morishita Y; Inadome Y; Minami Y; Iijima T; Fukai S; Goya T; Noguchi M
Cancer; 2005 Feb; 103(3):608-15. PubMed ID: 15612080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]